2026 POSTER PRESENTATIONS

P01: Democratizing Single Cell and Spatial Omics Analysis with Cloud Infrastructure and Agentic Workflows, Presented by Dylan W., 10x Genomics

P02: TableX: A Patent Chemical Structure and Data Extraction Tool, Presented by Shinichiro W., Alkermes, Inc.

P03: Making Medical Science Understandable: Large Language Model Platform for Patient-Friendly Content | Case Study, Presented by Lukasz N., Ardigen

P04: From Public Repositories to Target Hypotheses – An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs, Presented by Dawid R., Ardigen

P05: DiVenn 2: An Interactive Gene Set Visualization and Enrichment Analysis Tool for Single-Cell Rnaseq Data, Presented by Liang S., Boston Children's Hospital

P06: A Novel Imputation-Based Computational Strategy for the Identification of Tumor-Macrophage Hybrid Cells in Single-Cell RNA Sequencing Data Reveals a Transcriptional Phenotype Consistent with Metastatic Function, Presented by Alissa C., Bridge Informatics

P07: A Standardized Framework for Cloud-Based RNA-seq Pipeline Execution and Analysis Ready Outputs, Presented by Alissa C., Bridge Informatics

P08: From Administrative Hurdle to Automated Decision Support: Scaling Institutional Governance with DUOS, Presented by Sofia L., Broad Institute of MIT and Harvard

P09: Through.bio: See the Clinical Impact of Basic Research, Presented by Eric W., Broad Institute of MIT and Harvard

P10: LaunchAi-Transformed Experiences and Data-Driven Insights to Navigate Regulatory Complexity, Market Access & Clinical Innovation, Presented by Kaveri L., CapeStart

P11: A Multi-Agent Architecture for Evidence Synthesis and Report Generation in Life Sciences, Presented by Kavin X., CapeStart

P12: Radically Accelerate Drug Discovery & Development Using Agentic AI, Presented by Dhaval P., ChapsVision

P13: Integrating Machine Learning and Automation to Advance Retrosynthesis Planning and Custom Chemical Synthesis, Presented by Arthur L., Chemical.AI

P14: A Governance Framework for Responsible Generative AI in Clinical Text Validated via AI Nursing Handoff, Presented by Chia-Jung C., Chi Mei Hospital

P15: Agent Based Platform for Medication Safety Monitoring Utilizing Generative AI, Presented by Chung-Feng L., Chi Mei Hospital

P16: An End-to-End AI-Enabled Platform for Automated Liver Organoid Toxicity Screening, Presented by Sina D., Cincinnati Children's Hospital Medical Center

P17: Data-Driven Multi-Omics Identifies Ribosome Export as a Therapeutic Bottleneck in Advanced Prostate Cancer, Presented by Yigang B., City of Hope National Medical Center

P18: Accelerating Research with SciDataHub: A Governed Platform for Delivering Scientific Apps and APIs, Presented by Sarah E., Cogent Biosciences

P19: Extracting and Harmonizing Marker Gene Signatures from Literature for AI-Ready Cell Type Annotation and Translational Research with CellKb, Presented by Ashwini P., Combinatics

P20: Cresset In Silico Solutions - Harnessing Digital Transformation to Drive Workflow Efficiencies, Presented by Jessica P., Cresset Biomolecular Discovery Ltd.

P21: Real World Evidence and Artificial Intelligence: Entering a New Era of Evidence Generation, Presented by Sam P., Deloitte

P22: High-Throughput Antibody Structure and Ensemble Protein Property Predictions, Presented by Méliné S., Discngine

P23: AI-Assisted Data Exploration in Bioinformatics Platforms for Early Drug Discovery, Presented by Robin B., ENPICOM B.V.

P24: Improving Safety in Life Sciences with AI: How EPAM Partnered with the FDA Group to Build the Audit Intelligence Compliance Assistant, Presented by Annika M., EPAM Systems, Inc.

P25: Astrolabe Project: Applying an AI Drug Discovery Model System to Reshape Multi-Modal R&D Workflows and Drive Precision Efficiency, Presented by Keyi J., Fosun Pharmaceutical Group Co., Ltd.

P26: Aqua Vista: Building a Clinical R&D Lakehouse to Drive the Shift from Passive QA to Active Risk Management, Presented by Keyi J., Fosun Pharmaceutical Group Co., Ltd.

P27: PharmAID: A Next-Generation Cognitive AI Engine Redefining Pharmaceutical Intelligence and Clinical Workflows, Presented by Jingjun Q., Fosun Pharmaceutical Group Co., Ltd.

P28: MedAlkaid: A Scalable Multi-Agent Al Platform Revolutionizing the Medical Research, Presented by Xingli W., Fosun Pharmaceutical Group Co., Ltd.

P29: Genomic and AI-Driven Discovery of Antifungal Determinants of Streptomyces Melanosporofaciens STM-2, Presented by Muhammed OG., Fu Jen Catholic University

P30: Next Era of Bioprocessing: Driving Innovation Through Digital CMC and AI, Presented by Jana H., Genedata AG

P31: A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates, Presented by Chris M., Genedata AG

P32: Beyond AI Estimates: Curated Evidence from Published Biomedical Research Identifies 83% More Patients and Expands Clinically Actionable Variant Coverage by 129%, Presented by Joe J., Genomenon, Inc.

P33: An LLM-Powered Evidence Gap Map of Longevity Interventions Across the 12 Hallmarks of Aging, Presented by Carsten U., German Heart Centre Munich, TUM Klinikum

P34: Mechanistically Interpretable Toxicity Prediction Through Multimodal Integration of Structure and Transcriptomics, Presented by Guillaume C., Ghent University

P35: Bioinformatics-Based Mechanistic Insights into SLFN11-Mediated Chemosensitivity by EZH1/2 Dual Inhibitor HM97662, Presented by Aran P., Hanmi Pharmaceutical Co., Ltd.

P36: Machine Learning-Guided, In Silico Design of Prime Editing Gene Therapy to Restore Tumor Suppressing Function to TP53 Gene Through Mutation Correction, Presented by Aashritha S., Hockaday School

P37: Automating Viral Clearance Prior Knowledge: An Ontology-Based Data Integration Pipeline, Presented by Lisa W., Johnson & Johnson Pharmaceutical R&D

P38: Autoimmune Disease Research Using Lifebit's Federated Trusted Research Environment (TRE), Presented by John G., Lifebit Biotech, Inc.

P39: Parameter Optimization for Quantitative Metagenomic Analysis of Xenic Cultures in a Biomanufacturing Setting, Presented by Emily L., Lumen Bioscience

P40: SYNTHIA Retrosynthesis & API: Accelerating In Silico Pathway Design, Presented by Manishi P., MilliporeSigma

P41: Multi‑Cloud Orchestration for Bioinformatic Pipelines, Presented by Ben H., Myriad Genetics, Inc.

P42: scEMB: Learning Context Representation of Genes Based on Large-Scale Single-Cell Transcriptomics, Presented by Kang-Lin H., National Center for High-Performance Computing

P43: Efficient Data Structures for Optical Neural Imaging: Scalable Sparse Matching via CRS Format, Presented by Yen-Jen L., National Center for High-Performance Computing

P44: Discovering Anticancer Drug Target Combinations via Network-Informed Signaling-Based Approach, Presented by Bengi Y., National Institutes of Health, National Cancer Institute

P45: Faster NCBI BLAST Protein Searches, Presented by Grzegorz B., National Institutes of Health, National Center for Biotechnology Information

P46: The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS), Presented by Natalia V., National Institutes of Health, National Institute of Neurological Disorders and Stroke

P47: Machine Learning Approach for Signal Processing in Diffuse In Vivo Flow Cytometry, Presented by Mehrnoosh E., Northeastern University

P48: ML-Enabled Diffuse In Vivo Flow Cytometry Device for In Vivo Circulating Tumor Cell Enumeration, Presented by Jane L., Northeastern University

P49: FlexFS-Backed Nextflow Framework for Scalable, Multimodal Bioinformatics Pipeline Execution, Presented by Chris D., Paradigm4

P50: BioLens: A Scalable Platform for GWAS Summary Statistics Visualization, Integration, and Meta-Analysis, Presented by Srikant S., Paradigm4

P51: A Fully Transparent and Automatable Form of AI for Biomarker and New Target Discovery Using Focal Graphs and Diverse Multi-Omics Data, Presented by Jed G., Plex Research, Inc.

P52: Multi-Agent Orchestration for Multi-Omics Discovery Using the PromptBio Platform, Presented by Sharon Z., PromptBio

P53: Multi-Omics Machine Learning Approach for Oesophageal Adenocarcinoma Prognosis, Presented by Bonnie W., QIMR Berghofer Medical Research Institute

P54: Predicting Trial Success Before Readout: AI-Driven Simulation Leveraging a Biomedical Knowledge Graph and Real-World Data, Presented by Heather A., QuantHealth

P55: Hybrid AI+Quantum Drug Discovery: The QuMO Multi-Objective Molecular Optimization Platform, Presented by Sungmin L., Qunova Computing, Inc.

P56: The Variance Is the Signal - Decomposing Epigenetic Clock Discordance into Meaningful Components, Presented by Steffen U., QuoData GmbH

P57: Curating the Huntingtin Interactome with Claude Code as an Agentic Extraction Workflow, Presented by Viktoria A., Rancho Biosciences

P58: FlowInsight: Automation of Clinical Flow Cytometry Data Workflows for Enhanced Delivery and Traceability, Presented by James B. & Elizabeth O., Rancho Biosciences

P59: Unlocking Perturb-seq Through Harmonization and Scalable Exploration, Presented by Ben E., Rancho Biosciences

P60: Data Alliances: A Collaborative Opportunity for FAIR and AI-Ready Data, Presented by Hillary M., Rancho Biosciences

P61: ROBOKOP: Accelerating Biomedical Discovery Through an Open Knowledge Graph Platform, Presented by Karamarie F., Renaissance Computing Institute (RENCI) at UNC-Chapel Hill

P62: Drug Repurposing with an Intelligent Orchestrating Platform, Presented by Yin-Hsong H., Repurgenesis Co., Ltd.

P63: A Deep Learning Approach for Modeling Large-Scale Cell Signaling Dynamics, Presented by Yiqi Y., Rutgers University

P64: Integrated AI and Physics-Based Methodologies for In-Silico Target Identification, Presented by Anatoly B., SandboxAQ

P65: PD-KG: A Multi-Omic Knowledge Graph for Parkinson’s Disease Discovery, Presented by Brook S., SandboxAQ

P66: Binder2030: Standardized Binding Data to Benchmark and Calibrate AI Models for Membrane Protein Drug Discovery, Presented by Tiffany N., SEEDSUPPLY, Inc.

P67: Molecule to Medication: Ontology Marks the Path, Presented by Doug B., Semantic Arts

P68: A Metadata-Driven AI Chatbot for Exploring Omics Data at Scale, Presented by Radhakrishna B., Strand Life Sciences

P69: OMOP Mapping and Automated Metadata Harmonization for UK Biobank, Presented by Badri P., Strand Life Sciences

P70: A Unified Foundation Model Framework for Drug-Response Prediction in Human Cell Types, Presented by Badri P., Strand Life Sciences

P71: AI-Assisted Clinical Data Curation for Longitudinal Brain Disease Cohorts: Improving Data Quality, Traceability, and Operational Efficiency, Presented by Sujung O., Sungkyunkwan University

P72: Integrating Agentic AI in TrueDesign Genome Editor for Guided Design of Genome Editing Experiments, Presented by Mudra H., Thermo Fisher Scientific

P73: Streamlining LLM Access for Teaching, Research and Learning via Open OnDemand at Tufts, Presented by Shirley L., Tufts University

P74: Molecular Landscape of Colorectal Cancer (CRC) with KRAS 13D Mutations, Presented by Anesu M., University of Arizona

P75: Validation Artifacts Dominate Performance in Cytometry and Optical Biomedical Datasets, Presented by Adam W. & Kamil W., University of Gdansk

P76: Interactive UMAP-Based Platform for Exploration and Quantitative Analysis of Flow Cytometry Data, Presented by Katarzyna W., University of Gdansk

P78: Uncovering Intra-Population Genomic Variation in the Puerto Rican Monarch (Danaus plexippus portoricensis) Through Pangenome Assembly, Presented by Julian SP., University of Puerto Rico

P79: Knowledge Graph Embeddings Enable Patient Matching and Gene Prioritization in Rare Disease Diagnosis, Presented by Christina A., University of Utah

P80: AI/ML Meets siRNA: Accelerating Antiviral Discovery, Presented by Evan S., Weston High School

P81: A Federated Learning System for Organoid Image Analysis, Presented by Dechang X., Xi'an Jiaotong-Liverpool University

P82: From Chaos to Clarity: Can AI/ML Truly Decode Unstructured Clinical Data?, Presented by Umamaheswari A., Zifo Technologies, Inc.

P83: From System Exports to Standards: Will Standardisation of External Vendor Data Redefine Clinical Data Management/Analysis?, Presented by Sai D., Zifo Technologies, Inc.

P84: Multi-Omics Integration and Signature Curation for Psoriasis: A Reproducible Framework for Target Discovery, Presented by Mohamed K., Zifo Technologies, Inc.

P85: A Canonical Framework for Multi-Dimensional Retrosynthetic Scoring, Presented by Mohamed K., Zifo Technologies, Inc.

P86: CHiP-FL: A Federated Learning Framework for Equitable ICU Risk Modeling, Presented by Rhea Z., Cary Academy